Experienced in Rubella

Dr. Janet A. Englund

Pediatric Infectious Disease | Pediatrics
4800 Sand Point Way Ne, 
Seattle, WA 
Accepting New Patients
Offers Telehealth
Experienced in Rubella
4800 Sand Point Way Ne, 
Seattle, WA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Janet Englund is a Pediatric Infectious Disease specialist and a Pediatrics provider in Seattle, Washington. Dr. Englund is rated as an Experienced provider by MediFind in the treatment of Rubella. Her top areas of expertise are Parainfluenza, Tetanus, Infantile Neutropenia, and Pertussis. Dr. Englund is currently accepting new patients.

Her clinical research consists of co-authoring 367 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Rubella.

Specialties
Pediatric Infectious Disease
Pediatrics
Licenses
Pediatric Infectious Diseases in WA
Languages Spoken
English
Castilian
French
German
Romanian
Spanish
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

PacificSource
  • PPO
Premera
  • EPO
  • PPO

Locations

4800 Sand Point Way Ne, Seattle, WA 98105

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Comparison of High vs. Standard Dose Flu Vaccine in Pediatric Stem Cell Transplant Recipients
Comparison of High vs. Standard Dose Flu Vaccine in Pediatric Stem Cell Transplant Recipients
Enrollment Status: Completed
Publish Date: October 22, 2024
Intervention Type: Biological, Other
Study Phase: Phase 2
An Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
An Intermediate-size, Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
Enrollment Status: No_longer_available
Publish Date: March 14, 2022
Intervention Type: Drug
Study to Assess the Safety, Overall Tolerability, and Antiviral Activity of Brincidofovir Versus Standard of Care for Treatment of Adenovirus in High-risk Pediatric Allogeneic Hematopoietic Transplant Recipients
Study to Assess the Safety, Overall Tolerability, and Antiviral Activity of Brincidofovir Versus Standard of Care for Treatment of Adenovirus in High-risk Pediatric Allogeneic Hematopoietic Transplant Recipients
Enrollment Status: Terminated
Publish Date: January 25, 2021
Intervention Type: Other, Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

367 Total Publications

Corrigendum to 'American Society for Transplantation and Cellular Therapy Series #10: Management of Parainfluenza and Human Metapneumovirus Infections in Hematopoietic Cell Transplantation and Cellular Therapy Recipients' [Transplantation and Cellular Therapy 31 (2025) 624-638/ https://doi.org/10.1016/j.jtct.2025.06.016].
Corrigendum to 'American Society for Transplantation and Cellular Therapy Series #10: Management of Parainfluenza and Human Metapneumovirus Infections in Hematopoietic Cell Transplantation and Cellular Therapy Recipients' [Transplantation and Cellular Therapy 31 (2025) 624-638/ https://doi.org/10.1016/j.jtct.2025.06.016].
Journal: Transplantation and cellular therapy
Published: October 18, 2025
Similar Doctors
Experienced in Rubella
Dr. Hans D. Ochs
Pediatric Allergy and Immunology | Pediatrics | Allergy and Immunology
Experienced in Rubella
Dr. Hans D. Ochs
Pediatric Allergy and Immunology | Pediatrics | Allergy and Immunology

The Association Of Chrmc And University Physicians

4800 Sand Point Way Ne, 
Seattle, WA 
 (0.1 miles away)
206-526-2000
Languages Spoken:
English, Arabic, French, German, Italian
See accepted insurances
Accepting New Patients
Offers Telehealth

Hans Ochs is a Pediatric Allergy and Immunologist and a Pediatrics provider in Seattle, Washington. Dr. Ochs is rated as a Distinguished provider by MediFind in the treatment of Rubella. His top areas of expertise are Wiskott-Aldrich Syndrome, Primary Immunodeficiency (PID), X-Linked Agammaglobulinemia, and Immunodeficiency with Hyper IgM Type 1. Dr. Ochs is currently accepting new patients.

Experienced in Rubella
Dr. Alastair F. Murray
Pediatrics
Experienced in Rubella
Dr. Alastair F. Murray
Pediatrics
4800 Sand Point Way Ne # Oc.7830, 
Seattle, WA 
 (0.1 miles away)
206-987-2525
Languages Spoken:
English
See accepted insurances

Alastair Murray is a Pediatrics provider in Seattle, Washington. Dr. Murray is rated as an Experienced provider by MediFind in the treatment of Rubella. His top areas of expertise are Rubella and Measles.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Englund's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile